Envy Medical Congratulates Zaina Pharma, Inc., in partnership with AMAREY NOVA MEDICAL S.A., through Amarey’s subsidiary Estelena S.A., on a very successful launch of the Lumixyl Topical Brightening System the national Aesthetic Surgery Congress in Medellin, Columbia August 26th & 27th, 2010. Top physicians from around the country crowded presentation halls to hear about the break-through technology, Decapeptide-12, at the heart of the
Felipe Jimenez, Ph.D. discusses Lumixyl with the President of the Columbia Aethetic Surgery Association.
Lumixyl Topical Brightening System. Developed by a team of Stanford University Dermatologists and Researchers, Lumixyl is clinically shown to be as effective as hydroquinone in inhibiting tyrosinase, one of the key enzymes responsible for creating the pigment in skin.
The Lumixyl Brightening System is not only an innovation in skin brightening technology; it is a series of innovations that were designed in four cascading formulations. Each product in the System has been engineered individually to promote your brightest, healthiest skin. Together as a system, they amplify that result, all without the need of hydroquinone (HQ) or HQ bi-products. The Lumixyl Brightening System is an entirely new approach to naturally brighter, more vibrant skin, representing a new physician-grade standard in skincare.
With a well trained staff and commitment to excellence, we are confident that Amarey will have great success with the Envy Medical line of Lumixyl products. Lumixyl is now available through Dermatologists and Cosmetic Surgeons throughout Columbia.
About Zaina Pharma, Inc.
Zaina Pharma is a healthcare company specialized in the development, in-licensing and marketing of pharmaceutical, medical device and cosmetic products around the world. Zaina commercializes products through its network of local marketing partners, and is able to adapt global marketing strategies to fit local needs. For more information visit www.zainapharma.com
About Amarey Nova Medical, S.A.
Amarey Nova Medical S.A. is a specialized Enterprise for distribution, commercialization and sales of pharmaceutical products manufactured by recognized pharmaceutical houses for the Colombian hospital-pharmaceutical market.
In the same way our main strategy is the high investment in continued medical education for the Colombian physicians, which conform our main objective.
About Envy Medical, Inc.,
Felipe Jiminez, Ph.D. Presents Lumixyl Data to Physicians
Envy Medical develops, markets and sells highly effective non-invasive skin rejuvenation therapies for patients suffering from either dermatologic or aesthetic conditions. The Company’s lead products include SilkPeel®, a breakthrough device combining exfoliation with dermalinfusion® for deeper tissue delivery of active ingredients and better patient outcomes. Envy is also the exclusive licensor of skin brightening peptides including Lumixyl, developed at Stanford University. The Lumixyl peptide is now also available as a topical solution for SilkPeel procedures, addressing hyperpigmentation and photo-damage. More information can be found at www.envymedical.com.
For more information on Lumixyl or to locate a dispensing physician near you, please contact: info@envymedical.com.
For media inquiries or to secure expert testimonial please contact Melissa Kelz, Principal, Melissa Kelz PR at melissakelz@kelzpr.com 312.543.8300
Launch in Bogota & Medellin with the Lumixyl Columbia Team Front Row: Felipe Jiminez (Envy CSO), Claudia, Paula, Marcela, Angelica Back Row: Jairo Ayala, Paul Gillbaud (Zaina Pharma)
Pingback: Tweets that mention Lumixyl Enters South America | Envymedical's Blog -- Topsy.com